Baseline Metabolic Tumor Volume and Total Lesion Glycolysis Are Associated With Survival Outcomes in Patients With Locally Advanced Pancreatic Cancer Receiving Stereotactic Body Radiation Therapy
- 18 April 2014
- journal article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 89 (3), 539-546
- https://doi.org/10.1016/j.ijrobp.2014.02.031
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Recent progress in pancreatic cancerCA: A Cancer Journal for Clinicians, 2013
- Cancer statistics, 2013CA: A Cancer Journal for Clinicians, 2013
- Noise Considerations for PET Quantification Using Maximum and Peak Standardized Uptake ValueJournal of Nuclear Medicine, 2012
- Standard uptake value and metabolic tumor volume of 18F-FDG PET/CT predict short-term outcome early in the course of chemoradiotherapy in advanced non-small cell lung cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 2011
- Adjuvant Chemoradiation Therapy for Adenocarcinoma of the Distal PancreasAnnals of Surgical Oncology, 2010
- 18F-FDG PET/CT for Image-Guided and Intensity-Modulated RadiotherapyJournal of Nuclear Medicine, 2009
- From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid TumorsJournal of Nuclear Medicine, 2009
- DPC4 Gene Status of the Primary Carcinoma Correlates With Patterns of Failure in Patients With Pancreatic CancerJournal of Clinical Oncology, 2009
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Analysis of Fluorouracil-Based Adjuvant Chemotherapy and Radiation After Pancreaticoduodenectomy for Ductal Adenocarcinoma of the Pancreas: Results of a Large, Prospectively Collected Database at the Johns Hopkins HospitalJournal of Clinical Oncology, 2008